Page last updated: 2024-09-04

(1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum (ii) and Breast Neoplasms

(1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum (ii) has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernhardt, G; Schlemmer, R; Schönenberger, H; Spruss, T2

Other Studies

2 other study(ies) available for (1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum (ii) and Breast Neoplasms

ArticleYear
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)et
    Archiv der Pharmazie, 2000, Volume: 333, Issue:12

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cyclosporine; Female; Humans; Immunity; Immunologic Factors; Immunosuppressive Agents; Mice; Mice, Inbred Strains; Organoplatinum Compounds; T-Lymphocytes; Transplantation, Heterologous; Tumor Cells, Cultured

2000
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes in B6D2F1 mice.
    Archiv der Pharmazie, 2000, Volume: 333, Issue:12

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Division; Female; Humans; Immunity, Cellular; Immunologic Factors; Mice; Mice, Inbred Strains; Organoplatinum Compounds; Phagocytes; Transplantation, Heterologous; Tumor Cells, Cultured

2000